An intriguing relationship between type 2 diabetes mellitus and hepatitis C virus infection: The renal perspective

Hepatitis Monthly

Volumn 9, Issue 2, 2009, Pages 89-91

  Saxena, Anil K ^a   Suresh, Raman B ^a  

^a CMHS   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE;

DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDITORIAL; EPIDEMIOLOGICAL DATA; GLOMERULONEPHRITIS; GLUCOSE INTOLERANCE; HEPATITIS C; HUMAN; INFECTION RISK; INSULIN RESISTANCE; INTRAVENOUS DRUG ABUSE; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; VIRUS TRANSMISSION;

EID: 70349275769     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Editorial

References (19)

1. Rodriguez JA, Cleries M, Vela E. Diabetic patients on renal replacement therapy: analysis of Catalan Registry data. Renal Registry Committee. Nephrol Dial Transplant. 1997;12(12):2501-9.
2. Miles AM, Friedman EA. Dialytic therapy for diabetic patients with terminal renal failure. Curr Opin Nephrol Hypertens. 1993; 2(6):868-75.
3. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000; 133(8):592-9.
4. el-Zayadi AR, Selim OE, Hamdy H, Dabbous H, Ahdy A, Moniem SA. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol. 1998;19(4):141-4.
5. Grimbert S, Valensi P, Levy-Marchal C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol. 1996;20(6-7):544-8.
6. Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999; 30(4):1059-63.
7. Aytug S, Reich D, Sapiro L, Bernstein D, Begum N. Impaired IRS-1/ PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology. 2003;38(6):1384- 92
8. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care. 1996;19(9):998-1000.
9. Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001; 24(6):1044-9.
10. Ozyilkan E, Erbas T, Simsek H, Telatar F, Kayhan B, Telatar H. Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus. J Intern Med. 1994;235(3):283-4.
11. Sangiorgio L, Attardo T, Gangemi R, Rubino C, Barone M, Lunetta M. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res Clin Pract. 2000;48(2):147-51.
12. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med Wkly. 2003;133(45-46): 611-8.
13. Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia: role of oxidative stress. Blood Purif. 2002;20(5):481-4.
14. Kalantar-Zadeh K, Ikizler T, Block G, Avram M, Kopple J. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. American Journal of Kidney Diseases. 2003; 42(5):864-81.
15. Martin P, Fabrizi F. Hepatitis C virus and kidney disease. J Hepatol. 2008;49(4):613-24.
16. Tsui JI, Vittinghoff E, Shlipak MG, et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med. 2007;167(12):1271-6.
17. Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002; 36(5 Suppl 1):S93-8.
18. Howard AA, Klein RS, Schoenbaum EE. Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis. 2003;36(10):1318-23.
19. Saxena AK, Panhotra BR, Al-Ghamdi AM. Remarkable resemblance in the mode of transmission of HCV infection among haemodialysis patients and IVDAs. Gut. 203;52(11):1656-7.